ABOUT OUTLOOK THERAPEUTICS
Outlook Therapeutics (Nasdaq: OTLK) is a commercial-stage biopharmaceutical company redefining the standard of care in retinal disease. Our lead product is the first ophthalmic formulation of its molecule to receive Marketing Authorization from the European Commission and the UK MHRA for the treatment of wet age-related macular degeneration (wet AMD), and is now launching across Germany, Austria, and the UK. In the United States, where the product is investigational, we recently won our FDA appeal and resubmitted our Biologics License Application, putting us on a potential path to becoming the first FDA-approved ophthalmic bevacizumab. Driven by the stories of the patients we serve, we are united with the vision-care community around a single goal: a future where everyone with retinal disease can envision a brighter world.
THE OPPORTUNITY
This is a rare ground-floor moment at a company hitting its commercial inflection point. As a lean, fast-moving organization, we offer scope and ownership that larger companies can’t: your work is visible, your decisions matter, and you’ll help build the function rather than simply maintain it. You’ll partner directly with senior leadership and see a clear line between what you do and patients gaining access to a new treatment option.
In this role, you own the enablement engine behind our field organization — arming Key Account Managers, Business Engagement Managers, and Field Reimbursement Managers with the tools, insights, and strategic innovation that turn launch potential into unit growth and patient access. You are the connective tissue between commercial strategy and field execution at the most consequential moment in the company’s history.
WHAT YOU’LL DO
Field Enablement & Execution
Strategic Innovation
Buy/Bill & Field Force Effectiveness
Market Opportunity & Territory Optimization
Launch Readiness
WHAT YOU’LL BRING
Required
Preferred
WHAT WE OFFER
COMPENSATION
In keeping with our commitment to pay transparency, the good-faith base salary range for this role is $205,000 – $250,000, with an annual target bonus of 20% and eligibility for a meaningful equity grant. Final compensation reflects experience, skills, and location.
OUR COMMITMENT
Outlook Therapeutics is an equal opportunity employer. We are committed to building an inclusive environment where every team member can do their best work, and we consider all qualified applicants without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, veteran status, or any other characteristic protected by law.
Sr. Director, Strategic Innovation & Business Development
Mckesson
Strategic Account Development Executive, Platform Innovation
DoorDash USA
Strategic Finance, AI Innovation
Figma
Senior Director, TAAP Strategic Innovation Partner
Thomsonreuters
Managing Director - Strategic Sales Growth and Innovation
Creditacceptance
Associate Strategic Initiatives Manager-Venture, Innovation and Growth
Msk